Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × Temozolomide × Clear all

NCT06617923 2025-10-27

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

Phase 2 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms